Skip to main content

Peer Review reports

From: The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data

Original Submission
13 Jun 2019 Submitted Original manuscript
5 Sep 2019 Author responded Author comments - Pablo Fernandez-Navarro
25 Jul 2019 Reviewed Reviewer Report - Hideo Baba
27 Jul 2019 Reviewed Reviewer Report - hiba abdul-adheem
Resubmission - Version 2
5 Sep 2019 Submitted Manuscript version 2
24 Sep 2019 Author responded Author comments - Pablo Fernandez-Navarro
17 Sep 2019 Reviewed Reviewer Report - Hideo Baba
19 Sep 2019 Reviewed Reviewer Report - hiba abdul-adheem
Resubmission - Version 3
24 Sep 2019 Submitted Manuscript version 3
Publishing
25 Sep 2019 Editorially accepted
26 Oct 2019 Article published 10.1186/s12885-019-6209-9

You can find further information about peer review here.

Back to article page